The second session of Otolaryngology Rounds 2025, a specialized virtual event presented by Cleveland Clinic Abu Dhabi, convened on Saturday, November 15, 2025, for an in- depth exploration of contemporary thyroid cancer management. Titled "Thyroid Cancer Update 2025," this Round 2 session provided a cutting-edge, case-integrated curriculum that directly connected the latest international guidelines with complex clinical decision- making.
The program, moderated by Dr. Samer El-Kaissi and Dr. Mahdi Shkoukani, was structured into three focused modules. Module 1 addressed evolving paradigms in surgical and adjuvant care. World-renowned expert Dr. Yasuhiro Ito presented critical updates on active surveillance for papillary thyroid microcarcinoma and the rationale for hemithyroidectomy in non-hereditary medullary thyroid carcinoma. This was followed by a vital discussion on long-term safety from Dr. Cari Kitahara, who examined the risk of secondary malignancies associated with radioactive iodine. A robust international panel discussion synthesized these insights, featuring perspectives from experts including Dr. Aly Bernard and Dr. Naveed Ahmed.
Module 2 was dedicated to the highly anticipated preview of the 2025 American Thyroid Association (ATA) Guidelines. Esteemed committee members Dr. Trevor Angell and Dr. Marika Russell provided exclusive early insights into the new recommendations for thyroid nodule evaluation and the updated management strategies for differentiated thyroid cancer, setting the stage for imminent practice changes.
The session culminated with Module 3, featuring a keynote lecture by the distinguished Dr. Gregory Randolph on the emerging frontier of neoadjuvant treatment for thyroid cancer. The educational experience was anchored by an extensive, multidisciplinary Tumor Board. This interactive segment brought together endocrinologists, surgeons, pathologists, and nuclear medicine specialists to deliberate on complex, real-world cases, applying the day’s updates on guidelines, surveillance, and novel therapies directly to challenging patient scenarios.
By seamlessly blending guideline previews, expert lectures on controversial topics, and a dynamic tumor board, Otolaryngology Rounds 2025 | Round 2 delivered a highly practical and forward-looking update. It successfully equipped attendees with the nuanced understanding required to navigate the modern, personalized approach to thyroid cancer care.
